(Q34871632)

English

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme

scientific article

Statements

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme (English)
Susan Burdette-Radoux

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit